| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |